oral chlamydia - HEALTHIES
San Antonio Current: UT Health San Antonio leading $11 million study of oral vaccine for chlamydia UT Health San Antonio leading $11 million study of oral vaccine for chlamydia News Medical: UT Health San Antonio leads effort for developing oral vaccine against chlamydia The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in National Institutes of Health funding over five years through a ... UT Health San Antonio leads effort for developing oral vaccine against chlamydia EurekAlert!: UT Health San Antonio to lead $11 million, NIH-funded study of a first-ever oral chlamydia vaccine SAN ANTONIO, – The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in National Institutes of Health funding over ... UT Health San Antonio to lead $11 million, NIH-funded study of a first-ever oral chlamydia vaccine Blue Water Vaccines Inc.
Understanding the Context
has signed an exclusive, global license agreement for the development of a live attenuated, oral chlamydia vaccine candidate from The University of Texas (UT) Health San ...